Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 May;16(2):564–567. doi: 10.1128/iai.16.2.564-567.1977

Effect of levamisole on Mycobacterium leprae in mice.

C C Shepard, R Van Landingham, L L Walker
PMCID: PMC420993  PMID: 324914

Abstract

Levamisole, an antihelminthic drug that is capable of enhancing immune responses in mice and in humans, was tested in experimental Mycobacterium leprae infections in mice by a number of schedules. Intermittent schedules were used, and administration of the drug was started (i) around the time of inoculation with M. leprae, (ii) when the M. leprae population was approaching the plateau level, (iii) after the onset of the plateau phase, or (iv) after BCG vaccination 28 days following the inoculation with M. leprae. No effect of drug could be discerned with any of the schedules.

Full text

PDF
564

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bullock W. E., Jr, Fasal P. Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response. J Immunol. 1971 Apr;106(4):888–899. [PubMed] [Google Scholar]
  2. Chan S. H., Lee S. K., Simons M. J., Stanley N. F. Levamisole augmentation of lymphocyte hyporesponsiveness to phytohaemagglutinin in patients with pulmonary tuberculosis. Proc Soc Exp Biol Med. 1976 Apr;151(4):716–719. doi: 10.3181/00379727-151-39292. [DOI] [PubMed] [Google Scholar]
  3. Copeland D., Stewart T., Harris J. Effect of levamisole (NSC-177023) on in vitro human lymphocyte transformation. Cancer Chemother Rep. 1974 Mar-Apr;58(2):167–170. [PubMed] [Google Scholar]
  4. Dierks R. E., Shepard C. C. Effect of phytohemagglutinin and various mycobacterial antigens on lymphocyte cultures from leprosy patients. Proc Soc Exp Biol Med. 1968 Feb;127(2):391–395. doi: 10.3181/00379727-127-32698. [DOI] [PubMed] [Google Scholar]
  5. Dwyer J. M., Bullock W. E., Fields J. P. Disturbance of the blood T:B lymphocyte ratio in lepromatous leprosy. Clinical and immunologic correlations. N Engl J Med. 1973 May 17;288(20):1036–1039. doi: 10.1056/NEJM197305172882002. [DOI] [PubMed] [Google Scholar]
  6. Fidler I. J., Spitler L. E. Effects of levamisole on in vivo and in vitro murine host response to syngeneic transplantable tumor. J Natl Cancer Inst. 1975 Nov;55(5):1107–1112. doi: 10.1093/jnci/55.5.1107. [DOI] [PubMed] [Google Scholar]
  7. Hoebeke J., Franchi G. Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc. 1973 Sep;14(3):317–323. [PubMed] [Google Scholar]
  8. Irwin M. R., Knight H. D. Enhanced resistance to Corynebacterium pseudotuberculosis infections associated with reduced serum immunoglobulin levels in levamisole-treated mice. Infect Immun. 1975 Nov;12(5):1098–1103. doi: 10.1128/iai.12.5.1098-1103.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Levy L., Ng H., Evans M. J., Krahenbuhl J. L. Susceptibility of thymectomized and irradiated mice to challenge with several organisms and the effect of dapsone on infection with Mycobacterium leprae. Infect Immun. 1975 May;11(5):1122–1132. doi: 10.1128/iai.11.5.1122-1132.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lim S. D., Kiszkiss D. F., Jacobson R. R., Choi Y. S., Good R. A. Thymus-dependent lymphocytes of peripheral blood in leprosy patients. Infect Immun. 1974 Feb;9(2):394–399. doi: 10.1128/iai.9.2.394-399.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nelson D. S., Nelson M., Thurston J. M., Waters M. F., Pearson J. M. Phytohaemagglutinin-induced lymphocyte transformation in leprosy. Clin Exp Immunol. 1971 Jul;9(1):33–43. [PMC free article] [PubMed] [Google Scholar]
  12. Perk K., Chirigos M. A., Fuhrman F., Pettigrew H. Some aspects of host response to levamisole after chemotherapy in a murine leukemia. J Natl Cancer Inst. 1975 Jan;54(1):253–256. doi: 10.1093/jnci/54.1.253. [DOI] [PubMed] [Google Scholar]
  13. Ramot B., Biniaminov M., Shoham C., Rosenthal E. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease. N Engl J Med. 1976 Apr 8;294(15):809–811. doi: 10.1056/NEJM197604082941504. [DOI] [PubMed] [Google Scholar]
  14. Renoux G., Renoux M. Action de phénylimidothiazole (tétramisole) sur la réaction de greffon contre l'hôte. Rôle des macrophages. C R Acad Sci Hebd Seances Acad Sci D. 1972 Jun 12;274(24):3320–3323. [PubMed] [Google Scholar]
  15. Renoux G., Renoux M. Action immunostimulante de dérivés du phénylimidothiazole sur les cellules spléniques formatrices d'anticorps. C R Acad Sci Hebd Seances Acad Sci D. 1972 Jan 31;274(5):756–757. [PubMed] [Google Scholar]
  16. Renoux G., Renoux M. Effet immunostimulant d'un Imidothiazole dans l'immunisation des souris contre l'infection par Brucella abortus. C R Acad Sci Hebd Seances Acad Sci D. 1971 Jan 11;272(2):349–350. [PubMed] [Google Scholar]
  17. Renoux G., Renoux M. Stimulation of anti-Brucella vaccination in mice by tetramisole, a phenyl-imidothiazole salt. Infect Immun. 1973 Oct;8(4):544–548. doi: 10.1128/iai.8.4.544-548.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ridley D. S. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ. 1974;51(5):451–465. [PMC free article] [PubMed] [Google Scholar]
  19. Sampson D., Lui A. The effect of levamisole on cell-mediated immunity and suppressor cell function. Cancer Res. 1976 Mar;36(3):952–955. [PubMed] [Google Scholar]
  20. Shepard C. C. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392. Int J Lepr Other Mycobact Dis. 1969 Oct-Dec;37(4):389–397. [PubMed] [Google Scholar]
  21. Shepard C. C., McRae D. H. A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):78–82. [PubMed] [Google Scholar]
  22. Shepard C. C., Van Landingham R., Walker L. L. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions. Infect Immun. 1976 Oct;14(4):919–928. doi: 10.1128/iai.14.4.919-928.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thienpont D., Brugmans J., Abadi K., Tanamal S. Tetramisole in the treatment of nematode infections in man. Am J Trop Med Hyg. 1969 Jul;18(4):520–525. doi: 10.4269/ajtmh.1969.18.520. [DOI] [PubMed] [Google Scholar]
  24. Thienpont D., Vanparijs O. F., Raeymaekers A. H., Vandenberk J., Demoen J. A., Allewijn F. T., Marsboom R. P., Niemegeers C. J., Schellekens K. H., Janssen P. A. Tetramisole (R 8299), a new, potent broad spectrum anthelmintic. Nature. 1966 Mar 12;209(5028):1084–1086. doi: 10.1038/2091084a0. [DOI] [PubMed] [Google Scholar]
  25. Tripodi D., Parks L. C., Brugmans J. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. N Engl J Med. 1973 Aug 16;289(7):354–357. doi: 10.1056/NEJM197308162890707. [DOI] [PubMed] [Google Scholar]
  26. Van den Bossche H., Janssen P. A. The biochemical mechanism of action of the antinematodal drug tetramisole. Biochem Pharmacol. 1969 Jan;18(1):35–42. doi: 10.1016/0006-2952(69)90006-9. [DOI] [PubMed] [Google Scholar]
  27. Wachi K. K., Kimura L. H., Perreira S., Hokama Y., Perri S., Palumbo N. Effect of levamisole and C-reactive protein on mitogen-stimulated lymphocytes in vitro. Res Commun Chem Pathol Pharmacol. 1974 Aug;8(4):681–696. [PubMed] [Google Scholar]
  28. Whitcomb M. E., Merluzzi V. J., Cooperband S. R. The effect of levamisole on human lymphocyte mediator production in vitro. Cell Immunol. 1976 Feb;21(2):272–277. doi: 10.1016/0008-8749(76)90056-3. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES